TotalMarketCap

Macrogenics

MGNXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$143.325 M

$2.25 -2.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Macrogenics (MGNX) has a market capitalization of $143.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$149.5M

#2373 by revenue

Earnings

-$74.6K

Loss-making

Shares outstanding

63,700,187

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #264Sionna TherapeuticsSION$147.8M
  2. #265Atrium TherapeuticsRNA$143.5M
  3. #266MacrogenicsMGNX$143.3M
  4. #267Alx OncologyALXO$143.0M
  5. #268Nervgen PharmaNGEN$141.0M

What if Macrogenics were worth as much as…

Open the what-if tool →

Gold $28.2T

$443,277.72

Per share 197,012× higher

Bitcoin $1.53T

$23,984.99

Per share 10,660× higher

Apple $5.02T

$78,740.47

Per share 34,996× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Macrogenics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.